Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.
Read Full NewsPublished phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.
Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders
Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia
FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies
Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates
1.
Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.
2.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
3.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
4.
Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.
5.
Depression risk higher among long-term breast cancer survivors than women without breast cancer history
1.
Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments
2.
The Latest Research on Wiskott Aldrich Syndrome
3.
Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies
4.
Unlocking The Power Of Cangrelor To Treat Heart Disease
5.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge